Piper Sandler Upgrades Neogen to Overweight, Raises Price Target to $14
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsUpgradesPrice Target
Piper Sandler analyst David Westenberg upgrades Neogen (NASDAQ:NEOG) from Neutral to Overweight and raises the price target from $13 to $14.
Piper Sandler analyst David Westenberg upgrades Neogen (NASDAQ:NEOG) from Neutral to Overweight and raises the price target from $13 to $14.